News | March 27, 2008

FDA Clears Toshiba CT Solutions to Lower Dose, Speed Workflow

March 28, 2008 - Toshiba America Medical Systems Inc. received FDA clearance for two new CT clinical applications, SURECardio Prospective and Variable Helical Pitch (vHP), designed to improve throughput and enhance workflow, while further reducing contrast and radiation dosage.

The applications are available for new Toshiba Aquilion 32- and 64-slice CT systems.

Toshiba's SURECardio Prospective aims to help reduce patient dose by up to 80 percent during coronary CTA exams by using a helical acquisition technique to provide one continuous image instead of multiple images produced by the current step-and-shoot techniques. SURECardio Prospective is said to automatically detect and adjust to patients with arrthymia, for quicker, more conclusive exam results.
It is also engineered to automate scan parameters and reconstruction based on the patient's heart rate. It also speeds exam time and eliminates the need to use additional contrast as with the step-and-shoot method.

Variable Helical Pitch (vHP) increases workflow and efficiency by enabling physicians to complete an exam of more than one anatomical region consecutively – without stopping to alter the helical pitch of the exam. With vHP, according to the manufacturer, the patient's gated heart and non-gated body can be imaged during a single exam, reducing patient radiation and contrast dose and saving critical time for the imaging center or hospital. This feature targets the needs of trauma centers, in particular.
vHP also reportedly saves time by producing one comprehensive image instead of two separate images that would result from separate scans. This eliminates the task of piecing together separate images.
Both clinical applications are available to purchase independently and will be offered with all new Aquilion 32 and 64 CT systems.

For more information: www.medical.toshiba.com

Related Content

iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...
HeartFlow Announces New Commercial Coverage With UnitedHealthcare
News | Computed Tomography (CT) | July 03, 2018
HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45...
Post-Mortem CT Angiography Illuminates Causes of Death
News | CT Angiography (CTA) | June 25, 2018
Computed tomography (CT) angiography is a useful adjunct to autopsy that is likely to increase the quality of post-...
360 Photos | 360 View Photos | June 14, 2018
This is a 360 degree image from the Canon Aquilion 64-slice...
360 Photos | 360 View Photos | May 02, 2018
This is a 360 degree image from the Canon Aquilion One 320-slice computed tomography (CT) system installed at...
iSchemaView Receives FDA Clearance for Rapid CTA
Technology | CT Angiography (CTA) | May 01, 2018
Cerebrovascular imaging analysis company iSchemaView received final clearance from the U.S. Food and Drug...
HeartFlow FFRct Analysis Added to ITP Payment Program in the U.K.
News | CT Angiography (CTA) | April 25, 2018
HeartFlow Inc. announced that the National Health Service (NHS) England has chosen the HeartFlow FFRct (fractional flow...
New Policy Decisions Give Millions Access to HeartFlow FFRct Analysis
News | Cardiac Imaging | February 01, 2018
February 1, 2018 – HeartFlow announced that seven new commercial payers issued positive medical policies covering the
Overlay Init